Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON BETA-1B for Multiple sclerosis relapse: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 28 adverse event reports in the FDA FAERS database where INTERFERON BETA-1B was used for Multiple sclerosis relapse.

Most Reported Side Effects for INTERFERON BETA-1B

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 1,229 10.0% 12 312
Influenza like illness 1,042 8.4% 1 110
Injection site pain 1,014 8.2% 3 122
Fatigue 783 6.3% 9 130
Drug ineffective 767 6.2% 7 53
Injection site erythema 724 5.9% 1 73
Injection site reaction 707 5.7% 0 86
Pain 597 4.8% 6 115
Headache 596 4.8% 6 134
Multiple sclerosis 589 4.8% 24 116
Gait disturbance 525 4.3% 7 157
Death 501 4.1% 501 41
Injection site bruising 480 3.9% 0 32
Pyrexia 475 3.9% 10 135
Chills 460 3.7% 3 69

Other Indications for INTERFERON BETA-1B

Multiple sclerosis (7,192) Product used for unknown indication (842) Relapsing-remitting multiple sclerosis (694) Secondary progressive multiple sclerosis (146) Covid-19 (93) Chronic myeloid leukaemia (26) Clinically isolated syndrome (18) Covid-19 pneumonia (16) Relapsing multiple sclerosis (15) Hepatitis c (13)

Other Drugs Used for Multiple sclerosis relapse

OCRELIZUMAB (373) FINGOLIMOD (355) METHYLPREDNISOLONE (291) TERIFLUNOMIDE (216) CORTICOTROPIN (173) OFATUMUMAB (158) ALEMTUZUMAB (155) GLATIRAMER (133) OZANIMOD (84) SIPONIMOD (70)

Related Pages

INTERFERON BETA-1B Full Profile All Multiple sclerosis relapse Drugs INTERFERON BETA-1B Demographics INTERFERON BETA-1B Timeline